Early Results of Sotatercept Treatment in Patients With Severe Pulmonary Hypertension and a Potts Shunt
ABSTRACT Twelve patients with severe pulmonary hypertension (PH) who had a pulmonary artery‐to‐descending aorta (Potts) shunt were treated with the novel PH drug sotatercept for an average of 12 months. Overall, the group showed significant improvement in a number of clinical parameters with no seri...
Gorde:
| Egile Nagusiak: | , , , |
|---|---|
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Wiley
2026-04-01
|
| Saila: | Pulmonary Circulation |
| Gaiak: | |
| Sarrera elektronikoa: | https://doi.org/10.1002/pul2.70296 |
| Etiketak: |
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|